Biography:

David W. Anstice, President, Human Health, is responsible for the Japan, Latin America, Canada, Australia, and New Zealand human health pharmaceutical businesses of Merck & Co., Inc., a world leader in the discovery, development, manufacture and marketing of human health products.  He is also responsible for Merck’s joint ventures with Schering-Plough.  He reports to the Chairman & Chief Executive Officer of Merck & Co. Inc., Mr. Raymond V. Gilmartin, and serves on Merck’s Management Committee.

His most recent assignment was President, Human Health, The Americas.  From September 1994 through December 2002, he was responsible for Merck’s human health businesses for North America, including direct responsibility for the U.S. market as President, U.S. Human Health.  In January 1997, Mr. Anstice’s responsibilities were expanded to include the Latin American group.  Mr. Anstice was promoted to the position of President, Human Health, U.S./Canada in September 1994 from his preceding assignment as President, Human Health Europe.  An Economics graduate of the University of Sydney in Australia, Mr. Anstice joined Merck in 1974 in Australia.  Prior to his European assignment, he progressed through a series of positions of increasing responsibility, including Managing Director, Merck Sharp & Dohme Australia; Vice President, International Human Health Marketing, Merck Sharp & Dohme International; Vice President, Marketing, Merck Sharp & Dohme, U.S.A.; and President, U.S. Human Health in April 1991.

Mr. Anstice serves as a Member, Board of Directors, BIO (Biotechnology Industry Organization), Washington, DC.  Other professional activities Member, Board of Trustees, University of the Sciences in Philadelphia, Philadelphia, PA; Member, Advisory Board of Managers, Morris Arboretum, Philadelphia, PA; Member, CEO Council for Growth, Philadelphia, PA; Chairman, Board of the University of Sydney USA Foundation; and Member, Corporate Advisory Council, The National Alliance for Hispanic Health.  He served as Chairman of the National Pharmaceutical Council, Reston, VA in 1997.

Back to Schedule